Close
| |

Home Page

Company Database

Licensing Deals

Investors

Latest updates

04 May 2016
Updates within the latest 30 days:

News in the Life Sciences Industry

Results 1 - 20 out of 500 displayed.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 - Next
Reset 

Essilor: Disclosure of Share Capital and Voting Rights Outstanding as of April 30, 2016

Read more ››
By: Nasdaq / GlobenewsWire - 04 May 2016
Related companies:  Essilor International

Sanofi: Annual General Shareholder Meeting of May 4, 2016

Read more ››
By: Nasdaq / GlobenewsWire - 04 May 2016
Related companies:  Sanofi S.A.

Novavax Reports First Quarter 2016 Financial Results

Read more ››
By: Nasdaq / GlobenewsWire - 04 May 2016
Related companies:  Novavax, Inc.

Cardinal Health Board of Directors Approves Quarterly Dividend, Authorizes Share Repurchase Program

DUBLIN, Ohio, May 4, 2016 /PRNewswire/ -- Cardinal Health today announced that its board of directors approved a 16 percent increase in the company's quarterly dividend to $0.4489 per share, or $1.80 per share on an annualized basis. The quarterly dividend is payable on July 15, 2016, to shareholders... Read more ››

By: PR Newswire Association LLC. - 04 May 2016
Related companies:  Cardinal Health

Echo Therapeutics Announces Final Closing of Private Placement of $5.1 Million of Convertible Notes and Warrants

ISELIN, N.J., May 4, 2016 /PRNewswire/ -- Echo Therapeutics, Inc. (Nasdaq: ECTE), a medical device company focused on non-invasive, needle-free continuous glucose monitoring (CGM) and associated technologies, today announced the final closing of a previously announced $5,145,000 private placement... Read more ››

By: PR Newswire Association LLC. - 04 May 2016
Related companies:  Echo Therapeutics

Helsinn Announces Top-Line Results of its Phase IIb Trial With Elsiglutide for the Prevention of Chemotherapy-induced Diarrhea in Colorectal Cancer Patients

LUGANO, Switzerland, May 4, 2016 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 04 May 2016

Blue Cross and Blue Shield of Minnesota Appoints Elizabeth Moran to Leadership Position in Government Markets Business Areas

EAGAN, Minn., May 4, 2016 /PRNewswire-USNewswire/ -- Blue Cross and Blue Shield of Minnesota (Blue Cross) today announced that Elizabeth (Betsy) Moran has been named vice president and CEO of the Blue Cross and Blue Shield Northern Plains Alliance, a consortium of six regional Blue Cross and... Read more ››

By: PR Newswire Association LLC. - 04 May 2016

Ns1ghter Launches Free and Unlimited Doctor Visits

AUSTIN, Texas, May 4, 2016 /PRNewswire/ -- Ns1ghter announced its no cost, open source health service today. Ns1ghter will be offering unlimited access to their U.S. board certified doctors to anyone, free of charge. Their goal is to remove barriers, which prevent patients from understanding... Read more ››

By: PR Newswire Association LLC. - 04 May 2016

Dr. Dan McCoy Named President of Blue Cross and Blue Shield of Texas

RICHARDSON, Texas, May 4, 2016 /PRNewswire-USNewswire/ -- Health Care Service Corporation (HCSC) today announced that Dr. Dan McCoy has been named President of Blue Cross and Blue Shield of Texas (BCBSTX), effective July 1, 2016. Dr. McCoy succeeds Bert Marshall who will retire after 20 years... Read more ››

By: PR Newswire Association LLC. - 04 May 2016

Supervised Autonomous In Vivo Robotic Surgery on Soft Tissues is Feasible and Outperforms Standard Surgery Techniques According to Study from the Sheikh Zayed Institute for Pediatric Surgical Innovation at Children's National Health System

WASHINGTON, May 4, 2016 /PRNewswire-USNewswire/ -- Surgeons and scientists from the Sheikh Zayed Institute for Pediatric Surgical Innovation at Read more ››

By: PR Newswire Association LLC. - 04 May 2016

Europe Thyroid Cancer Market Analysis - Trends, Technologies & Opportunities Report 2016-2020 - Research and Markets

DUBLIN, May 5, 2016 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 04 May 2016
Related companies:  Ascendiant Capital Markets LLC

GIQuIC Colonoscopy Quality Registry Reaches 3 Million Colonoscopy Cases

BETHESDA, Md., May 4, 2016 /PRNewswire-USNewswire/ -- The dramatic growth in the number of colonoscopies reported through the GI Quality Improvement Consortium, Ltd. (GIQuIC) registry reached 3,000,000 cases in April. GIQuIC is a national registry that fosters the ability of endoscopists and... Read more ››

By: PR Newswire Association LLC. - 04 May 2016

Abbott to Present at Deutsche Bank Health Care Conference

ABBOTT PARK, Ill., May 4, 2016 /PRNewswire/ -- Abbott (NYSE: ABT) will present at the Deutsche Bank 41(st) Annual Health Care Conference on Thursday, May 5, 2016. Tom Freyman, executive vice president, finance and administration, and Brian Yoor, senior vice president, finance and chief financial... Read more ››

By: PR Newswire Association LLC. - 04 May 2016
Related companies:  Abbott Laboratories

Vanda Pharmaceuticals Reports First Quarter 2016 Financial Results

WASHINGTON, May 4, 2016 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), today announced financial and operational results for the first quarter ended March 31, 2016.

Read more ››
By: PR Newswire Association LLC. - 04 May 2016
Related companies:  Vanda Pharmaceuticals

Bruker Reports First Quarter 2016 Financial Results

BILLERICA, Mass., May 4, 2016 /PRNewswire/ -- Bruker Corporation (NASDAQ: BRKR) today reported financial results for its first quarter ended March 31, 2016.

Read more ››
By: PR Newswire Association LLC. - 04 May 2016
Related companies:  Bruker Daltonics Inc. | Bruker BioSpin Corporation

PDL BioPharma Announces 2016 Second Quarter Dividend

INCLINE VILLAGE, Nev., May 4, 2016 /PRNewswire/ -- PDL BioPharma, Inc. (NASDAQ: PDLI) today announced that its board of directors has declared a $0.05 per share dividend for the second quarter of 2016. The cash dividend will be paid on June 13, 2016 to all stockholders who own shares of PDL... Read more ››

By: PR Newswire Association LLC. - 04 May 2016
Related companies:  PDL BioPharma, Inc.

Roka Bioscience Reports First Quarter 2016 Financial Results

WARREN, N.J., May 4, 2016 /PRNewswire/ -- Roka Bioscience, Inc. (NASDAQ: ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens, today reported its financial results for the three months ended March 31, 2016.

Read more ››
By: PR Newswire Association LLC. - 04 May 2016
Related companies:  Roka Bioscience, Inc.

Orexigen Therapeutics Reports Business and Financial Results for the First Quarter Ended March 31, 2016

SAN DIEGO, May 4, 2016 /PRNewswire/ -- Orexigen Therapeutics, Inc. (Nasdaq: OREX) today announced business and financial results for the first quarter ended March 31, 2016.

Read more ››
By: PR Newswire Association LLC. - 04 May 2016
Related companies:  Orexigen Therapeutics, Inc.

Kindred Biosciences Submits KIND-010 New Animal Drug Application Technical Section for Chemistry, Manufacturing, and Controls to FDA

SAN FRANCISCO, May 4, 2016 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced the submission to FDA of the Chemistry, Manufacturing, and Controls (CMC) technical section of the New Animal Drug... Read more ››

By: PR Newswire Association LLC. - 04 May 2016
Related companies:  Kindred Biosciences, Inc.

PDL BioPharma Announces First Quarter 2016 Financial Results

INCLINE VILLAGE, Nev., May 4, 2016 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today reported financial results for the first quarter ended March 31, 2016 including:

Read more ››
By: PR Newswire Association LLC. - 04 May 2016
Related companies:  PDL BioPharma, Inc.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 - Next